Literature DB >> 18789828

Dosimetric comparison of IMRT vs. 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus.

Louis Fenkell1, Inna Kaminsky, Stephen Breen, Sophie Huang, Monique Van Prooijen, Jolie Ringash.   

Abstract

BACKGROUND AND
PURPOSE: Radiotherapy planning for cervical esophageal cancer is challenging. We compared IMRT and 3D conformal radiotherapy (CRT) with respect to conformality of target coverage and normal tissue sparing.
MATERIALS AND METHODS: We selected five patients with cervical esophagus cancer, who represented the heterogeneity of clinical cases, treated to radical dose and planned with Pinnacle v6.2. Target doses for CRT plans were 50, 60, and 70Gy (single-phase IMRT 56, 63, and 70). We compared PTV coverage by the 95% isodose (PTV(95)), conformality ratio (CR), conformation number (CN), and maximum or mean doses (D(max), D(mean)) to normal structures.
RESULTS: Median PTV(95) for IMRT plans for PTV70, PTV63, and PTV56 were 97%, 99%, and 98% (CRT 91%, 98%, and 85%). IMRT plans demonstrated lower D(max) to the spinal cord and brainstem (42 and 36Gy) compared to CRT (46 and 39Gy). Median left parotid D(mean) was 35Gy (IMRT) vs. 53Gy (CRT). Median right parotid D(mean) was 35Gy (IMRT) vs. 36Gy (CRT). The median CR50/56Gy was 1.4 (CRT) vs. 1.2 (IMRT), CR70Gy 1.7 (CRT) vs. 1.1 (IMRT). CN50/56 and CN70 values were 0.80 and 0.85 (IMRT) vs. 0.56 and 0.5 (CRT).
CONCLUSIONS: IMRT provides superior target volume coverage and conformality, with decreased dose to normal structures.

Entities:  

Mesh:

Year:  2008        PMID: 18789828     DOI: 10.1016/j.radonc.2008.08.008

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  57 in total

Review 1.  Technological advances in radiotherapy for esophageal cancer.

Authors:  Milan Vosmik; Jiri Petera; Igor Sirak; Miroslav Hodek; Petr Paluska; Jiri Dolezal; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2010-11-28       Impact factor: 5.742

Review 2.  Proton beam therapy for gastrointestinal cancers: past, present, and future.

Authors:  Shahed N Badiyan; Christopher L Hallemeier; Steven H Lin; Matthew D Hall; Michael D Chuong
Journal:  J Gastrointest Oncol       Date:  2018-10

3.  Definitive intensity-modulated radiotherapy compared with definitive conventional radiotherapy in cervical oesophageal squamous cell carcinoma.

Authors:  Caineng Cao; Jingwei Luo; Li Gao; Guozhen Xu; Junlin Yi; Xiaodong Huang; Kai Wang; Shiping Zhang; Yuan Qu; Suyan Li; Jianping Xiao; Zhong Zhang
Journal:  Radiol Med       Date:  2015-02-03       Impact factor: 3.469

4.  New conformity indices based on the calculation of distances between the target volume and the volume of reference isodose.

Authors:  J M Park; S-Y Park; S-J Ye; J H Kim; J Carlson; H-G Wu
Journal:  Br J Radiol       Date:  2014-09-16       Impact factor: 3.039

5.  Definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced cervical esophageal cancer.

Authors:  Hiroshi Okamoto; Yusuke Taniyama; Tadashi Sakurai; Takahiro Heishi; Jin Teshima; Chiaki Sato; Shota Maruyama; Ken Ito; Yu Onodera; Takuro Konno-Kumagai; Hirotaka Ishida; Takashi Kamei
Journal:  Esophagus       Date:  2018-06-15       Impact factor: 4.230

6.  Bayesian variable selection for a semi-competing risks model with three hazard functions.

Authors:  Andrew G Chapple; Marina Vannucci; Peter F Thall; Steven Lin
Journal:  Comput Stat Data Anal       Date:  2017-03-22       Impact factor: 1.681

7.  Using deep learning to predict beam-tunable Pareto optimal dose distribution for intensity-modulated radiation therapy.

Authors:  Gyanendra Bohara; Azar Sadeghnejad Barkousaraie; Steve Jiang; Dan Nguyen
Journal:  Med Phys       Date:  2020-08-02       Impact factor: 4.071

8.  Intensity-modulated radiation therapy versus para-aortic field radiotherapy to treat para-aortic lymph node metastasis in cervical cancer: prospective study.

Authors:  Xue-lian Du; Xiu-gui Sheng; Tao Jiang; Hao Yu; Yu-feng Yan; Rong Gao; Chun-hua Lu; Qing-shui Li
Journal:  Croat Med J       Date:  2010-06       Impact factor: 1.351

9.  Bayesian regression analyses of radiation modality effects on pericardial and pleural effusion and survival in esophageal cancer.

Authors:  Liru He; Andrew Chapple; Zhongxing Liao; Ritsuko Komaki; Peter F Thall; Steven H Lin
Journal:  Radiother Oncol       Date:  2016-08-22       Impact factor: 6.280

10.  Volumetric modulated arc therapy (VMAT) in the treatment of esophageal cancer patients.

Authors:  Stefania Martini; Francesca Arcadipane; Paolo Strignano; Rosella Spadi; Viviana Contu; Christian Fiandra; Riccardo Ragona; Giorgia Catalano; Maria Antonietta Satolli; Michele Camandona; Renato Romagnoli; Umberto Ricardi; Pierfrancesco Franco
Journal:  Med Oncol       Date:  2018-10-04       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.